Jürgen Brockmöller

22.5k total citations · 3 hit papers
236 papers, 13.8k citations indexed

About

Jürgen Brockmöller is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Jürgen Brockmöller has authored 236 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Oncology, 78 papers in Pharmacology and 68 papers in Molecular Biology. Recurrent topics in Jürgen Brockmöller's work include Pharmacogenetics and Drug Metabolism (76 papers), Drug Transport and Resistance Mechanisms (69 papers) and Pharmacological Effects and Toxicity Studies (33 papers). Jürgen Brockmöller is often cited by papers focused on Pharmacogenetics and Drug Metabolism (76 papers), Drug Transport and Resistance Mechanisms (69 papers) and Pharmacological Effects and Toxicity Studies (33 papers). Jürgen Brockmöller collaborates with scholars based in Germany, United States and Austria. Jürgen Brockmöller's co-authors include Ivar Roots, Steffen Bauer, Christoph Sachse, Mladen V. Tzvetkov, Julia Kirchheiner, Ingolf Cascorbi, Ingolf Meineke, Reinhold Kerb, Leszek Wojnowski and Ulrich M. Zanger and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jürgen Brockmöller

235 papers receiving 13.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.

1997 803 citations Jürgen Brockmöller, Ivar Roots et al. profile →
Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

1999 579 citations Jürgen Brockmöller, Ivar Roots et al. profile →
The genetic determinants of the CYP3A5 polymorphism

2001 560 citations Jürgen Brockmöller et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jürgen Brockmöller Germany	65	5.1k	4.0k	4.0k	2.7k	1.6k	236	13.8k
Ivar Roots Germany	68	5.9k 1.1×	4.7k 1.2×	4.9k 1.2×	3.3k 1.2×	1.8k 1.1×	253	16.4k
Ingolf Cascorbi Germany	57	2.7k 0.5×	4.1k 1.0×	5.6k 1.4×	3.4k 1.3×	758 0.5×	234	13.1k
Ulrich M. Zanger Germany	74	10.1k 2.0×	5.1k 1.3×	6.8k 1.7×	3.1k 1.2×	1.7k 1.1×	197	19.8k
J. Steven Leeder United States	58	5.1k 1.0×	2.3k 0.6×	2.6k 0.7×	4.2k 1.6×	2.1k 1.3×	248	13.3k
Andrea Gaedigk United States	60	8.9k 1.7×	2.7k 0.7×	3.0k 0.7×	3.6k 1.3×	2.1k 1.3×	237	13.7k
Paul B. Watkins United States	73	11.5k 2.2×	3.5k 0.9×	6.2k 1.6×	3.2k 1.2×	2.2k 1.4×	246	19.9k
David A. Flockhart United States	63	5.6k 1.1×	3.9k 1.0×	4.3k 1.1×	1.3k 0.5×	1.9k 1.2×	255	15.3k
Tsuyoshi Yokoi Japan	67	7.2k 1.4×	6.2k 1.5×	4.8k 1.2×	1.7k 0.6×	1.6k 1.0×	369	16.2k
Jeffrey R. Idle United Kingdom	70	6.4k 1.3×	6.4k 1.6×	3.3k 0.8×	1.4k 0.5×	1.0k 0.7×	270	15.7k
Richard B. Kim Canada	74	5.7k 1.1×	3.7k 0.9×	9.1k 2.3×	4.7k 1.8×	1.5k 1.0×	243	18.5k

Countries citing papers authored by Jürgen Brockmöller

Since Specialization

Citations

This map shows the geographic impact of Jürgen Brockmöller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Brockmöller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Brockmöller more than expected).

Fields of papers citing papers by Jürgen Brockmöller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Brockmöller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Brockmöller. The network helps show where Jürgen Brockmöller may publish in the future.

Co-authorship network of co-authors of Jürgen Brockmöller

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Brockmöller. A scholar is included among the top collaborators of Jürgen Brockmöller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Brockmöller. Jürgen Brockmöller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brockmöller, Jürgen, et al.. (2025). Transport of Small Aliphatic Amines by Polyspecific Solute Carriers: Deciphering Structure–Function Relationships. ACS Pharmacology & Translational Science. 8(8). 2777–2794.

Brockmöller, Jürgen, et al.. (2024). Intestinal Drug Absorption After Subarachnoid Hemorrhage and Elective Neurosurgery: Insights From Esomeprazole Pharmacokinetics. Critical Care Medicine. 53(1). e140–e150. 1 indexed citations

Jensen, Ole, et al.. (2024). Comprehensive characterization of the OCT1 phenylalanine-244-alanine substitution reveals highly substrate-dependent effects on transporter function. Journal of Biological Chemistry. 300(11). 107835–107835. 1 indexed citations

Brockmöller, Jürgen, Ruben Evertz, Karl Toischer, et al.. (2023). Oral Drug Absorption and Drug Disposition in Critically Ill Cardiac Patients. Pharmaceutics. 15(11). 2598–2598. 1 indexed citations

Jensen, Ole, et al.. (2022). Substrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2. Journal of Medicinal Chemistry. 65(18). 12403–12416. 21 indexed citations

Jensen, Ole, et al.. (2021). Identification of Novel High-Affinity Substrates of OCT1 Using Machine Learning-Guided Virtual Screening and Experimental Validation. Journal of Medicinal Chemistry. 64(5). 2762–2776. 25 indexed citations

Paulus, Walter, et al.. (2021). The roles of caffeine and corticosteroids in modulating cortical excitability after paired associative stimulation (PAS) and transcranial alternating current stimulation (tACS) in caffeine-naïve and caffeine-adapted subjects. Psychoneuroendocrinology. 127. 105201–105201. 7 indexed citations

Jensen, Ole, et al.. (2019). Variability and Heritability of Thiamine Pharmacokinetics With Focus on OCT1 Effects on Membrane Transport and Pharmacokinetics in Humans. Clinical Pharmacology & Therapeutics. 107(3). 628–638. 19 indexed citations

Brockmöller, Jürgen, et al.. (2018). Genomic Variation and Pharmacokinetics in Old Age: A Quantitative Review of Age‐ vs. Genotype‐Related Differences. Clinical Pharmacology & Therapeutics. 105(3). 625–640. 17 indexed citations

10.

Schütz, Ekkehard, Anna Fischer, Julia Beck, et al.. (2017). Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study. PLoS Medicine. 14(4). e1002286–e1002286. 148 indexed citations

11.

Matthaei, Johannes, Mladen V. Tzvetkov, Daniel Sehrt, et al.. (2016). Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters. Genome Medicine. 8(1). 119–119. 10 indexed citations

12.

Stingl, Julia & Jürgen Brockmöller. (2013). Personalisierte Pharmakotherapie. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 56(11). 1509–1521. 4 indexed citations

13.

Tzvetkov, Mladen V., Jürgen Brockmöller, Ivar Roots, & Julia Kirchheiner. (2008). Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment. Pharmacogenetics and Genomics. 18(6). 495–506. 63 indexed citations

14.

Kirchheiner, Julia, Ingolf Meineke, Uwe Fuhr, et al.. (2008). Impact of Genetic Polymorphisms in CYP2C8 and Rosiglitazone Intake on the Urinary Excretion of Dihydroxyeicosatrienoic Acids. Pharmacogenomics. 9(3). 277–288. 15 indexed citations

15.

Vormfelde, Stefan Viktor, David Sehrt, Mohammad R. Toliat, et al.. (2007). Genetic Variation in the Renal Sodium Transporters NKCC2, NCC, and ENaC in Relation to the Effects of Loop Diuretic Drugs. Clinical Pharmacology & Therapeutics. 82(3). 300–309. 26 indexed citations

16.

Kirchheiner, Julia, et al.. (2006). A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment. The Pharmacogenomics Journal. 7(1). 48–55. 76 indexed citations

17.

Vineis, Paolo, Herman Autrup, Jürgen Brockmöller, et al.. (2001). Current Smoking, Occupation, N-Acetyltransferase-2 and Bladder Cancer. Cancer Epidemiology and Prevention Biomarkers. 10(12). 1249–1252. 1 indexed citations

18.

Rost, Karl Ludwig, H. Brösicke, Jürgen Brockmöller, et al.. (1992). Increase of cytochrome P450IA2 activity by omeprazole: Evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin. Clinical Pharmacology & Therapeutics. 52(2). 170–180. 106 indexed citations

19.

Brockmöller, Jürgen, et al.. (1991). Determination of S-carboxymethyl-l-cysteine and some of its metabolites in urine and serum by high-performance liquid chromatography using fluorescent pre-column labelling. Journal of Chromatography B Biomedical Sciences and Applications. 571(1-2). 133–147. 22 indexed citations

20.

Brockmöller, Jürgen & Roza Maria Kamp. (1988). Cross-linked amino acids in the protein pair S13-S19 and sequence analysis of protein S13 of Bacillus stearothermophilus ribosomes. Biochemistry. 27(9). 3372–3381. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact